Disc Medicine Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for hematologic diseases. It aims to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis. Its pipeline includes bitopertin for erythropoietic porphyrias (EPs), including erythropoietic protoporphyria (EPP), X-linked protoporphyria (XLP), and Diamond-Blackfan Anemia (DBA); DISC-0974 for the treatment of anemia of myelofibrosis (MF) and anemia of chronic kidney disease (CKD); and DISC-3405 for the treatment of polycythemia vera (PV) and other hematologic disorders. In addition, the Company's preclinical programs include DISC-0998.

What symbol and exchange does Disc Medicine shares trade?

Disc Medicine trades on the NASDAQ stock market under the symbol IRON.

What is Disc Medicine stock price doing today?

As of November 5, 2026, IRON stock price declined to $78.47 with 639,351 million shares trading.

What is Disc Medicine's Beta?

IRON has a beta of 1.14, meaning it tends to be more sensitive to market movements. IRON has a correlation of 0.06 to the broad based SPY ETF.

How much is Disc Medicine worth?

IRON has a market cap of $3.48 billion. This is considered a Mid Cap stock.

How much money does Disc Medicine make?

Last quarter Disc Medicine reported $0 in Revenue and -$1.54 earnings per share. This fell short of revenue expectation by $-150,000 and exceeded earnings estimates by $.19.

What is the highest and lowest price Disc Medicine traded in the last 3 year period?

In the last 3 years, IRON traded as high as $99.50 and as low as $25.60.

What are the top ETFs holding Disc Medicine?

The top ETF exchange traded funds that IRON belongs to (by Net Assets): IWM, VTI, XBI, IWO, VXF.

Is Disc Medicine (IRON) a good investment?

IRON has underperformed the market in the last year with a return of -8.8%, while SPY returned +9.7%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in IRON shares. However, IRON has outperformed the market in the last 3 month and 2 week periods, returning +0.9% and +3.3%, while SPY returned -4.7% and -5.2%, respectively. This indicates IRON has been having a stronger performance recently.

What are the support and resistance levels for Disc Medicine (IRON)?

IRON support price is $80.31 and resistance is $86.25 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that IRON shares will trade within this expected range on the day.